Effects of Arzoxifene on Bone Mineral Density in Korean Postmenopausal Women With Osteoporosis.
Phase of Trial: Phase II
Latest Information Update: 07 May 2015
At a glance
- Drugs Arzoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 07 Jun 2017 Biomarkers information updated
- 18 Dec 2009 Actual patient number (91) added as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual end date (October 2009) added as reported by ClinicalTrials.gov.